Chemokine-binding protein and methods of use

Details Chemokine-binding protein and methods of use Chemokine-binding protein and methods of use

2011-02-22

2011-02-22

Yu, Misook (Department: 1642)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

C435S320100, C435S007240

Reexamination Certificate

active

07892727

ABSTRACT:
Described herein are chemokine-binding domains of THAP-family polypeptides and pharmaceutical compositions which include a polypeptide comprising a chemokine-binding domain of a THAP-family polypeptide. Also disclosed are methods of binding chemokines, inhibiting the activity of chemokines, detecting chemokines, and reducing the symptoms associated with a chemokine mediated or influenced condition by contacting the chemokine with an agent that includes a polypeptide comprising a chemokine binding domain of a THAP-family polypeptide.

REFERENCES:
patent: 4522811 (1985-06-01), Eppstein et al.
patent: 4656127 (1987-04-01), Mundy
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4736866 (1988-04-01), Leder et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4870009 (1989-09-01), Evans et al.
patent: 4873191 (1989-10-01), Wagner et al.
patent: 5073627 (1991-12-01), Curtis et al.
patent: 5096815 (1992-03-01), Ladner et al.
patent: 5116947 (1992-05-01), Pinori et al.
patent: 5116964 (1992-05-01), Capon et al.
patent: 5143854 (1992-09-01), Pirrung et al.
patent: 5198346 (1993-03-01), Ladner et al.
patent: 5219089 (1993-06-01), Kiolbasa et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5225539 (1993-07-01), Winter
patent: 5270181 (1993-12-01), McCoy et al.
patent: 5283317 (1994-02-01), Saifer et al.
patent: 5292646 (1994-03-01), McCoy et al.
patent: 5424186 (1995-06-01), Fodor et al.
patent: 5428130 (1995-06-01), Capon et al.
patent: 5434131 (1995-07-01), Linsley et al.
patent: 5457035 (1995-10-01), Baum et al.
patent: 5783667 (1998-07-01), Wang
patent: 5834419 (1998-11-01), McFadden et al.
patent: 5843778 (1998-12-01), Rosengard et al.
patent: 5871740 (1999-02-01), Smith
patent: 5897999 (1999-04-01), Vogelstein et al.
patent: 6191269 (2001-02-01), Pollock et al.
patent: 6221615 (2001-04-01), Chittenden et al.
patent: 6242569 (2001-06-01), Shu et al.
patent: 2002/0082206 (2002-06-01), Leach et al.
patent: 0 125 023 (1984-11-01), None
patent: 0 171 496 (1986-02-01), None
patent: 0 173 494 (1986-03-01), None
patent: 0 184 187 (1986-06-01), None
patent: 0 273 085 (1988-07-01), None
patent: 0 412 883 (1991-02-01), None
patent: 0 707 592 (1996-04-01), None
patent: 0 785 280 (1997-07-01), None
patent: 1074617 (2001-02-01), None
patent: WO 86/01533 (1986-03-01), None
patent: WO 87/02671 (1987-05-01), None
patent: WO 88/06630 (1988-09-01), None
patent: WO 90/02809 (1990-03-01), None
patent: WO 90/15070 (1990-12-01), None
patent: WO 91/17271 (1991-11-01), None
patent: WO 92/01047 (1992-01-01), None
patent: WO 92/09690 (1992-06-01), None
patent: WO 92/10092 (1992-06-01), None
patent: WO 92/15679 (1992-09-01), None
patent: WO 92/18619 (1992-10-01), None
patent: WO 92/20791 (1992-11-01), None
patent: WO 93/01288 (1993-01-01), None
patent: WO 93/10151 (1993-05-01), None
patent: WO 94/02502 (1994-02-01), None
patent: WO 94/10300 (1994-05-01), None
patent: WO 94/10308 (1994-05-01), None
patent: WO 95/11995 (1995-05-01), None
patent: WO 96/33730 (1996-10-01), None
patent: WO 97/11714 (1997-04-01), None
patent: WO 99/31236 (1999-06-01), None
patent: WO 00/06728 (2000-02-01), None
patent: WO 00/28047 (2000-05-01), None
patent: WO 00/58473 (2000-10-01), None
patent: WO 01/12659 (2001-02-01), None
patent: WO 01/57190 (2001-08-01), None
patent: WO2001057190 (2001-09-01), None
patent: WO 03/051917 (2003-06-01), None
patent: WO 2004/055050 (2004-07-01), None
Current Protocol in immunology, 1997, unit 6.1.
Current Protocol in immunology, 2000, unit 6.12.
sequence search result.
Abravaya, et al. 1995. Detection of point mutations with a modified ligase chain reaction (Gap-LCR).Nucleic Acids Research, 23(4):675-682.
Adams, et al, 1998, The Bcl-2 protein family: Arbiters of cell survival.Science, 281:1322-1326.
Alcalay et al. 1998. The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein.Molecular and Cellular Biology, 18(2):1084-1093.
Alcami, et al. 1998. Blockade of Chemokine Activity by a Soluble Chemokine Binding Protein from Vaccinia Virus,The Journal of Immunology, 160:624-633.
Alt, et al. 2002. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis.Eur. J. Immunol., 32:2133-2144.
Altschul, et al. 1990. Basic local alignment search tool.J. Mol. Biol., 215:403-410.
Altschul, et al. 1997. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs.Nucleic Acids Research, 25(17):3389-3402.
Amann, et al. 1988. Tightly regulatedtacpromoter vectors useful for the expression of unfused and fused proteins inEscherichia coli. Gene, 69:301-315.
Amersham Biosciences. Scintillation Proximity Assay Manual. pp. 1-81.
Ammann, et al. 1997. Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrongen deficiency.J. Clin. Invest., 99(7):1699-1703.
Arcone, et al. 1988. Identification of sequences responsible for acute-phase induction of human C-reactive protein.Nucleic Acids Research, 16(8):3195-3207.
Aruffo, Alejandro, 1998. Expression of Proteins in Mammalian Cells Transient Expression of Proteins using COS cells,Current Protocols in Molecular Biology, 16.12.1-16.12.7.
Aruffo, et al., 1991. CD62/P-Selectin Recognition of Myeloid and Tumor Cell Sulfatides,Cell, 67:35-44.
Ashkenazi, et al. 1991. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.Proc. Natl. Acad. Sci. USA, 88:10535-10539.
Ausubel, et al. (Eds.). 1998. Current Protocols in Molecular Biology, vol. 1, Unit 6.3.1-6.3.6. John Wiley & Sons, Inc.
Baggiolini, et al., 1997. Human Chemokines: An Update,Annu. Rev. lmmunol. 15:675-705.
Baggiolini, et al., 1998. Chemokines and leukocyte traffic,Nature, 392:565-568.
Baichwal, et al. 1986. “Vectors for gene transfer derived from animal DNA viruses: Transient and stable expression of transferred genes.” In Kucherlapati, R. (Ed.). Gene Transfer, pp. 117-147. New York: Plenum Press.
Baldari, et al. 1987. A novel leader peptide which allows efficient secretion of a fragment of human interleukin 1β inSaccharomyces cerevisiae. The EMBO Journal, 6(1):229-234.
Balint, et al. 1993. Antibody engineering by parsimonious mutagenesis.Gene, 137:109-118.
Barbas, et al. 1991. Assembly of combinatorial antibody libraries on phage surfaces: The gene III site.Proc. Natl. Acad. Sci. USA, 88:7978-7982.
Barbas, et al. 1992. Semisynthetie combinatorial antibody libraries: A chemical solution to the diversity problem.Proc. Natl. Acad. Sci. USA, 89:4457-4461.
Barradas, et al. 1999. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression.The EMBO Journal, 18(22):5362-6369.
Bartel, et al. 1993. Elimination of false positives that arise in using the two-hybrid system.BioTechniques, 14(6):920-924.
Bartlett, et al. 1996. Efficient expression of protein coding genes from the murine U1 small nuclear RNA promoters.Proc. Natl. Acad. Sci. USA, 93:8852-8857.
Beaucage et al. 1981. Deoxynucleoside phosphoramidites—A new class of key intermediates for deoxypolynucleotide synthesis.Tetrahedron Letters, 22(20):1859-1862.
Beidler, et al. 1988. Cloning and high level expression of a chimeric antibody with specificity for human carcinoembryonic antigen.The Journal of Immunology, 141(11):4053-4060.
Benvenisty, et al. 1986. Direct introduction of genes into rats and expression of the genes.Proc. Natl. Acad. Sci. USA, 83:9551-9555.
Berra, et al. 1997. Positioning atypical protein kinase C isoforms in the UV-induced apoptotic signaling cascade.Molecular and Cellular Biology, 17(8):4346-4354.
Besset, et al. 2000. Nuclear localization of PAPS synthetase 1: A sulfate activation pathway in the nucleus of eukaryotic cells.The FASEB Journal, 14:345-354.
Better et al. 1988.Escherichia colisecretion of an active chimeric antibody fragment.Science, 240:1041-1043.
Blackwell, et al 1990

Affiliated with

Also associated with

Rating

Chemokine-binding protein and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chemokine-binding protein and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemokine-binding protein and methods of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2643038